je.st
news
Bayer spending $100 million on Berkeley hemophilia drug facility
2015-04-30 00:03:52| Chemicals - Topix.net
Bayer HealthCare is spending $100 million over the next two years to build a product testing facility here for a new hemophilia drug, a project that will create 325,000 hours of construction work, officials said in a news conference Wednesday. Bayer's Berkeley campus, which spans three city blocks on 7th Street between Dwight Way and Grayson Street, manufactures a drug for people with hemophilia A called Kogenate.
Tags: million
drug
facility
spending
Category:Chemicals